Drug recall · February 23, 2022
Pyrazinamide Tablets recall
Why: cGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.
- Lots / codes
Lot #: 19B064A, Exp. Date 03/2022
- Quantity
- 5,477 bottles
- Company
- ANI Pharmaceuticals, Inc., Baudette, MN
- Distribution
- Nationwide within the United States
- Initiated
- February 15, 2022 · Voluntary: Firm initiated
- Classified
- February 17, 2022
- Reported
- February 23, 2022
- Ended
- October 25, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pyrazinamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.